Christina Ackermann

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bridgewater, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Andrew Fisher, Attorney-in-fact for Christina Ackermann
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christina Ackermann

Form 4 holding Officer

Bausch & Lomb Corp

Security class
Common Shares, No Par Value
Shares / value
146,677
Estimated value
$2,502,310
Report date
01 Mar 2023
Price
$17.06
Ownership
Direct
Form 4 holding Officer

Bausch & Lomb Corp

Security class
Non-Qualified Stock Options (right to purchase)
Shares / value
90,744
Estimated value
$1,439,200
Report date
01 Mar 2023
Price
$15.86
Ownership
Direct
Underlying class
Common Shares, No Par Value
Underlying amount
Form 4 holding EVP AND GENERAL COUNSEL

Bausch Health Companies Inc.

Security class
Common Shares, No Par Value
Shares / value
162,240
Estimated value
$1,301,165
Report date
10 Mar 2022
Price
$8.02
Ownership
Direct
Form 4 holding Director

CalciMedica, Inc.

Security class
Common Stock
Shares / value
1,429
Estimated value
$5,290
Report date
23 Mar 2023
Price
$3.70
Ownership
Direct
Form 4 holding Director

Verona Pharma plc

Security class
Restricted Share Units
Shares / value
96,000
Estimated value
Report date
25 Apr 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

Verona Pharma plc

Security class
Restricted Stock Units
Shares / value
72,000
Estimated value
Report date
01 Aug 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

CalciMedica, Inc.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
Report date
23 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Verona Pharma plc

Security class
Share Options (Right to Buy)
Shares / value
0
Estimated value
Report date
07 Oct 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Christina Ackermann

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .